Quan Lin

机构：Beijing University of Chinese Medicine, Jilin University, Wenzhou Medical University, Wenzhou Central Hospital, Guangxi Medicinal Botanical Garden, Shengli Oilfield Central Hospital, State Key Laboratory of Supramolecular Structure and Materials · ORCID：0000-0002-9255-3555

发表论文 80 篇 · 总被引 1397 次 · h-index 19

代表论文

• Successful targeting of the NRG1 fusion reveals durable response to afatinib in lung adenocarcinoma: a case report (2021 · Annals of Translational Medicine · 被引 17)
• Low toxicity ginsenoside Rg1-carbon nanodots as a potential therapeutic agent for human non-small cell lung cancer (2024 · Colloids and Surfaces B Biointerfaces · 被引 16)
• Urinary exosomal long noncoding RNAs serve as biomarkers for early detection of non-small cell lung cancer (2021 · Bioscience Reports · 被引 16)
• Genome-wide analysis of the R2R3-MYB gene family in Spatholobus suberectus and identification of its function in flavonoid biosynthesis (2023 · Frontiers in Plant Science · 被引 14)
• Education and cardiovascular diseases: a Mendelian randomization study (2024 · Frontiers in Cardiovascular Medicine · 被引 13)
• Analysis of the Spatholobus suberectus full-length transcriptome identified an R2R3-MYB transcription factor-encoding gene SsMYB158 that regulates flavonoid biosynthesis (2024 · Plant Physiology and Biochemistry · 被引 9)